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Late complications of thoracic endografts
Karthikeshwar Kasirajan, MD, Ross Milner, MD, PhD, and Elliot L. Chaikof, MD, PhD, Atlanta, GaINTRODUCTION
The use of endovascular grafts in the thoracic aorta has
emerged as a natural evolution of abdominal endografts.
However, the thoracic aorta has unique anatomic features,
with a distinctive biomechanical and hemodynamic envi-
ronment, that results in late complications that are specific
to devices used in this location. This chapter addresses the
late complications that are characteristic of the thoracic
aorta, excluding endoleaks (Table), which are dealt with in
greater detail in other chapters.
The descending thoracic aorta, unlike the abdominal
aorta, is relatively mobile in the chest, with few space-
limiting surrounding organs. The fixation points of the
aorta are sites of origin of major branch vessels, with a
relatively mobile aortic segment extending from the left
subclavian artery to the celiac artery. Thus, the thoracic
aorta elongates and angulates between these points with
the development of an aneurysmal segment. These fea-
tures, combined with an acute angle at the junction of the
distal aortic arch and descending thoracic aorta, exert a
complex pattern of dynamic circumferential, radial, tor-
sional, and axial forces on thoracic endografts. The stress
field is significantly different than that exerted on abdomi-
nal endografts, and as a consequence, a variety of unique
late complications have been noted. Minimizing the risk of
these complications requires careful patient selection and
will mandate continuing refinement in endograft design.
AORTIC WALL PERFORATION
Angulation between the arch and descending thoracic
aorta has made attaining adequate device fixation and suf-
ficient proximal seal a significant challenge. In response to
this challenge, many early stage devices used a proximal
bare spring configuration (Fig 1). Unfortunately, bare
spring perforations have been observed, particularly when
the apex of the bare spring is positioned against the outer
curve of the distal aortic arch. This phenomenon has been
attributed to repeated pulsation causing erosion of the apex
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94Aof the bare spring through the aortic wall. It has been more
common in cases of type B dissection, aggressive graft
oversizing, grafts with proximal bare springs, fixation in
diseased portions of the aorta, and poorly controlled hyper-
tension (Fig 2).1 To minimize the risk of this event, we
currently recommend placing the endograft across the left
subclavian artery in the horizontal portion of the aortic
arch. Covering the left subclavian artery can often be per-
formed without significant morbidity.2
Distal bare spring perforations have also been reported
and are also most likely when a distal landing zone is
selected that is immediately proximal to a region of acute
aortic angulation. In response to this problem, most de-
vices now have no bare springs or have been redesigned
with covered flared ends. In the event that the aorta con-
tains multiple kinks or angles, the use of three devices may
provide the additional option of shifting terminal segment
stress points away from sites of acute angulation (Fig 3).
DEVICE COLLAPSE
The current recommendation is to not oversize tho-
racic endografts by18%. This may not always be feasible,
especially in emergency situations where availability of suit-
able grafts may be limited. For example, the smallest diam-
eter of the only commercially approved thoracic endograft
in the United States is 26 mm, which is inappropriate for
many pediatric patients or young adults who have a small
aortic diameter. Although these devices can be deployed,
dramatic oversizing subjects the endograft to significant
compression forces and torque at the proximal descending
aortic angle.
Melissano et al3 reported disappointing results with an
EndoFit (Endomed, Inc, Phoenix, Ariz) stent-graft used to
treat a distal aortic arch aneurysm. The authors reported
graft collapse along the inner curve of the aortic arch caused
by the fracture of three stents. More recently, Idu et al4
reported the use of a Gore Thoracic Aortic Graft (TAG)
(W.L. Gore & Associates, Flagstaff, Ariz) device in a 20-
year old patient with a traumatic aortic transection. Because
of small aortic diameter, oversizing of nearly 40% led to late
graft collapse along the outer curvature.
Current evidence suggests that graft infolding or pleat-
ing, noted at initial endograft placement, may progress to
stent-graft collapse. When unavoidable oversizing leads to
pleating, as demonstrated by an intravenous ultrasound
(IVUS) study (Fig 4), repeat balloon dilatation, relining
the graft with a second device, or use of a giant Palmaz stent
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reported that the mean aortic diameter in trauma patients
was 19.3 mm, which highlights the need for smaller diam-
Fig 1. The proximal and bare spring configuration of the Talent
device assists in graft fixation.
Fig 2. Aortic perforation is noted from the leading end of the
proximal bare spring.
Table. Late complications of thoracic endografts
● Aortic wall perforation
● Device collapse
● Metal fracture
● Fabric erosion
● Suture breakage
● Pseudocoarctation
● Delayed reperfusion of false lumeneter endografts for this patient population.METAL FRACTURE, FABRIC EROSION,
SUTURE BREAKAGE
Circumferential, radial, and torsional stresses owing to
cyclic loading from repetitive aortic pulsations have led to
metal fatigue and failure in all thoracic endografts. The
structural integrity of graft and material may also be af-
fected by late morphologic remodeling of the aorta owing
to reduction in aneurysm volume. The Gore TAG device
was initially withdrawn from clinical trails because of mul-
tiple longitudinal fractures of an axial wire used primarily to
facilitate deployment. Twenty wire fractures have been
identified in 19 patients; 18 (90%) of these occurred in the
longitudinal spine and two in apical nitinol support rings
Fig 3. Use of three devices to help reduce stress points at points
of aortic angulation.
Fig 4. Graft infolds are observed on intravascular ultrasound scan
as a result of endograft oversizing.(Fig 5). In a single patient, a spine fracture produced a type
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new device.6 The deployment wire was removed in the
currently approved TAG device (Fig 6).
Late metal fatigue and graft material deterioration have
been noted in virtually every endograft used to date.7 Graft
material fatigue, though infrequent, has also been reported
in conventional polyester grafts and, in some rare instances,
with expanded polytetrafluoroethylene, usually 10 to 20
years after implantation.8 Many devices use polypropylene
sutures to fix the grafts to the metal frame (Cook, Bloom-
ington, Ind). This introduces an additional risk of suture
breakage.
Fortunately many of the lessons learned from the initial
experience with abdominal aortic aneurysm endografts
have resulted in thoracic devices being specifically designed
to avoid the fabric fatigue and suture breakage common in
older generation devices, such as the Vanguard (Boston
Scientific, Natick, Mass) or Stentor (MinTec Inc, Bahamas)
endografts.9 Combined with the relatively harsh environ-
ment in which stent-grafts must function, sterilization,
packaging, introduction into the delivery catheter, operator
Fig 5. Metal fracture is seen in both longitudinal spine and niti-
nol rings.
Fig 6. The Gore TAG device that is currently approved for use in
the United States.handling, and shelf aging may independently influence theoccurrence and timing of metal fracture, fabric erosion, and
ultimately, device failure.
PSEUDOCOARCTATION SYNDROME
Pseudocoarctation syndrome is primarily observed in
thoracic endografts that have been used to treat chronic
aortic dissection. The intimal flap in chronic aortic dissec-
tion is often quite thick (Fig 7) and does not immediately
reapproximate to the native aortic wall after endograft
placement. Additionally, the significant size disparity be-
tween the normal proximal aorta and the true lumen at the
entry point of dissection (Fig 8) can lead to device com-
pression (Fig 9). In contrast, this event is infrequent in
patients treated for acute dissection because the intimal flap
is thin and easily reapproximated by the stent-graft.
In patients treated for chronic type B dissection, we
Fig 7. Thickened dissection flap in a patient with a chronic type B
dissection.
Fig 8. A, Size disparity between normal proximal aorta and dis-
section segment. B, Stent-graft exclusion of false lumen with
obvious graft compression.have addressed pseudocoarctation with restraint, as aggres-
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in retrograde extension of the dissection or frank aortic
rupture (Fig 10). Indeed, a more conservative approach has
been advocated by a number of clinicians after potential
life-threatening complications followed aggressive balloon
remolding.1
Typically, if a pseudocoarctation is observed, we mea-
sure pull-back arterial pressures across the compressed seg-
ment. Frequently a pressure gradient is not present. In the
event of a significant pressure gradient, we have gently
Fig 9. A, Compressed true lumen at proximal entry point.
B, Completion angiogram demonstrates the appearance of a
“pseudocoarctation.” C, Computed tomogram demonstrates
thrombosis of the false lumen with the flow across the compressed
true lumen.balloon-dilated this segment and, if unsuccessful, per-formed repeat balloon dilatation at a later date. Fortu-
nately, we have not yet encountered acute aortic occlusion
as a consequence of a pseudocoarctation.
Once thrombosis of the false lumen is noted on follow-up
imaging, the stent-graft often remolds spontaneously to a
larger diameter (Fig 11). Currently, long-term data are not
available on the use of thoracic endografts for patients with
chronic type B dissection, but favorable intermediate-term
results are encouraging.
DELAYED REPERFUSION OF FALSE LUMEN
This phenomenon is most commonly observed in pa-
tients treated for a chronic type B dissection. Type B
dissections often extend to the iliac level (Fig 12) and
stent-graft repair is targeted to cover the primary entry
point alone. Thus, the distal end of the stent-graft is almost
always located in a diseased portion of the aorta. It is
generally unnecessary and frequently impossible to extend
the stent-graft to the iliac level, which would compromise
the origin of the celiac artery, the superior mesenteric
artery, and the renal arteries. Extended coverage also sub-
Fig 10. Iatrogenic retrograde aortic dissection caused by bare
spring perforation after aggressive balloon dilatation.stantially increases the risk of paraplegia.
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end of the stent-graft is at risk of eroding through the
dissection flap with late reappearance of flow in the false
lumen (Fig 13, A). We have noticed this event primarily in
patients with poorly controlled hypertension or excessive
neck angulation, or in the presence of an intramural hema-
toma at the distal landing zone. Reperfusion of the false
lumen can be treated with a distal extension of the stent-
graft (Fig 13, B). Adequate blood pressure control and
avoiding landing grafts just proximal to acute aortic angles
may also help to minimize the risk of this complication.
We have also observed delayed false lumen reperfusion
in a patient with a left subclavian artery that was coil-
embolized to prevent a type II endoleak during the initial
endograft placement (Fig 14). Subclavian exclusion is per-
haps best addressed with suture ligation, as opposed to coil
embolization.
Patients with type B dissection often have a dissection
Fig 11. A, Enlarged false lumen and compressed true lumen
before endograft placement. B, Complete false lumen thrombosis
with spontaneous enlargement of the true lumen.
Fig 12. Typical type B dissection extending to iliac arteries.flap extending into the right renal artery (Figure 15, A),causing a dynamic obstruction. Diagnosis is often possible
with a computed tomography (CT) angiogram, and the
dynamic motion of the flap is best evaluated by an IVUS
examination (Figure 15, B). Treatment requires placing a
self-expanding stent from the distal renal artery across the
false lumen into the true lumen (Fig 15, C and D).
CONCLUSIONS
Clinical trials for thoracic endografts have required a
minimum of 15 mm of normal, presumably healthy aorta
for proximal and distal seal zones. The approval of thoracic
stent-grafts as well as growing confidence in endovascular
skills has resulted in liberalization of case selection. This has
led many to consider patients for endovascular repair de-
spite the presence of suboptimal anatomy, including land-
ing sites in an aortic arch with atherosclerotic degeneration
or in regions of abrupt taper and acute angulation. Such a
strategy often necessitates repeated balloon molding and
Fig 13. A, Distal flare erosion through a dissection flap results in
late reperfusion of the false lumen. B, Reperfusion treated with a
distal extension cuff.
Fig 14. Delayed reperfusion of false lumen from retrograde
blood flow from the subclavian artery.graft oversizing to achieve an initial seal.
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be somewhat deceptive. This is particularly true in patients
with compromised anatomy, given an increased risk of late
device migration, module disconnection, and loss of device
Fig 15. A, Dissection flap extends into right renal artery as ob-
served by computed tomography imaging. B, Dynamic motion of
the flap in the renal artery as seen by an intravascular ultrasound
(IVUS) examination. C, A self-expanding stent from the right
renal artery extends across the false lumen into the true lumen.D,
IVUS image demonstrates the renal stent extending across the false
lumen into the true lumen.integrity, along with local erosion or frank rupture of theaortic wall. At present, the lack of long-term data and the
evolving nature of device design should prompt endovas-
cular specialists to exercise great care in patient selection.
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